Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR

AbstractCisplatin (DDP) is a potent chemotherapeutic; however, it can also cause acute kidney injury (AKI). Because of the complexity of the toxicity it induces, few effective methods exist for ameliorating any form of DDP-induced AKI. Recent research has suggested that the complement system is a po...

Full description

Bibliographic Details
Main Authors: Zhouyu Wen, Can Sun, Yan Lou, Juan Kong
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Immunotoxicology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/1547691X.2023.2248267
_version_ 1797434310227132416
author Zhouyu Wen
Can Sun
Yan Lou
Juan Kong
author_facet Zhouyu Wen
Can Sun
Yan Lou
Juan Kong
author_sort Zhouyu Wen
collection DOAJ
description AbstractCisplatin (DDP) is a potent chemotherapeutic; however, it can also cause acute kidney injury (AKI). Because of the complexity of the toxicity it induces, few effective methods exist for ameliorating any form of DDP-induced AKI. Recent research has suggested that the complement system is a potential molecular target for such amelioration. In the study here, in vivo (male ICR mice) and in vitro (HK-2 cells) models of DDP-induced AKI were established to investigate the potential therapeutic effects of Vitamin D (VD) against this form of AKI. Endpoints assessed in vivo/in vitro included overall renal function, degree of renal damage, and complement receptor C5aR expression using histology, immunohistochemistry, immunofluorescence, RT-PCR, and Western blots. The data indicated that the use of VD treatment could reduce renal pathological damage along with expression of TNFα, IL-1β, IL-18, and C5aR; however, an over-expression of C5aR weakened the protective effects of VD/VD receptor (VDR) against oxidative damage and inflammatory cell infiltration. Using a luciferase reporter gene assay and ChIP analysis, it was demonstrated that C5aR was transcriptionally inhibited by VDR. In conclusion, VD/VDR could delay DDP-induced AKI by inhibiting the expression of C5aR through transcriptional regulation and reducing the production of downstream pro-inflammatory cytokines. The present study revealed the regulatory mechanism of VD/VDR in acute renal inflammation and provides new insights into its therapeutic function in DDP-induced AKI.
first_indexed 2024-03-09T10:30:21Z
format Article
id doaj.art-aa10aada97a841d59b0445a81abb0028
institution Directory Open Access Journal
issn 1547-691X
1547-6901
language English
last_indexed 2024-03-09T10:30:21Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Immunotoxicology
spelling doaj.art-aa10aada97a841d59b0445a81abb00282023-12-01T21:19:05ZengTaylor & Francis GroupJournal of Immunotoxicology1547-691X1547-69012023-12-0120110.1080/1547691X.2023.2248267Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aRZhouyu Wen0Can Sun1Yan Lou2Juan Kong3Department of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang, ChinaDepartment of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang, ChinaDepartment of Computer Science, School of Intelligent Medicine, China Medical University, Shenyang, ChinaDepartment of Clinical Nutrition, Shengjing Hospital of China Medical University, Shenyang, ChinaAbstractCisplatin (DDP) is a potent chemotherapeutic; however, it can also cause acute kidney injury (AKI). Because of the complexity of the toxicity it induces, few effective methods exist for ameliorating any form of DDP-induced AKI. Recent research has suggested that the complement system is a potential molecular target for such amelioration. In the study here, in vivo (male ICR mice) and in vitro (HK-2 cells) models of DDP-induced AKI were established to investigate the potential therapeutic effects of Vitamin D (VD) against this form of AKI. Endpoints assessed in vivo/in vitro included overall renal function, degree of renal damage, and complement receptor C5aR expression using histology, immunohistochemistry, immunofluorescence, RT-PCR, and Western blots. The data indicated that the use of VD treatment could reduce renal pathological damage along with expression of TNFα, IL-1β, IL-18, and C5aR; however, an over-expression of C5aR weakened the protective effects of VD/VD receptor (VDR) against oxidative damage and inflammatory cell infiltration. Using a luciferase reporter gene assay and ChIP analysis, it was demonstrated that C5aR was transcriptionally inhibited by VDR. In conclusion, VD/VDR could delay DDP-induced AKI by inhibiting the expression of C5aR through transcriptional regulation and reducing the production of downstream pro-inflammatory cytokines. The present study revealed the regulatory mechanism of VD/VDR in acute renal inflammation and provides new insights into its therapeutic function in DDP-induced AKI.https://www.tandfonline.com/doi/10.1080/1547691X.2023.2248267Vitamin DC5aRcisplatinacute kidney injuryrenal inflammation
spellingShingle Zhouyu Wen
Can Sun
Yan Lou
Juan Kong
Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR
Journal of Immunotoxicology
Vitamin D
C5aR
cisplatin
acute kidney injury
renal inflammation
title Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR
title_full Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR
title_fullStr Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR
title_full_unstemmed Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR
title_short Vitamin D/Vitamin D receptor mitigates cisplatin-induced acute kidney injury by down-regulating C5aR
title_sort vitamin d vitamin d receptor mitigates cisplatin induced acute kidney injury by down regulating c5ar
topic Vitamin D
C5aR
cisplatin
acute kidney injury
renal inflammation
url https://www.tandfonline.com/doi/10.1080/1547691X.2023.2248267
work_keys_str_mv AT zhouyuwen vitamindvitamindreceptormitigatescisplatininducedacutekidneyinjurybydownregulatingc5ar
AT cansun vitamindvitamindreceptormitigatescisplatininducedacutekidneyinjurybydownregulatingc5ar
AT yanlou vitamindvitamindreceptormitigatescisplatininducedacutekidneyinjurybydownregulatingc5ar
AT juankong vitamindvitamindreceptormitigatescisplatininducedacutekidneyinjurybydownregulatingc5ar